Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms
2018
Background/Aims: Angiogenesis is extensively developed in well-differentiated pancreatic neuroendocrine tumours (PanNET) where sunitinib was shown to prolong prog
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
23
Citations
NaN
KQI